Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed discussions and signed a Material Transfer Agreement (MTA) with Pharmswell Co Ltd., based in Seoul, South Korea. The MTA covers the supply of the product ProVale(tm), from its Canadian facility.
Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed the first phase of the manufacturing scale-up at its Charlottetown facility. The increase in production will satisfy future demands for its newly acquired product ProVale(tm), manufactured at the facility.
Stirling Products (ASX: STI) advises that, following an announcement last week by the Canadian retailer Co-op Atlantic and its partner the Natural Organic Food Group (NOFG) that they will commence selling Omega-3 enhanced pork products, Stirling Products North America (SPNA) expects increased distribution sales revenue from its Omega-3 premix supplied to the partnership. SPNA, based on Prince Edward Island, Canada, has the exclusive rights to distribute the Omega-3 premix which is currently manufactured to proprietary specifications by KenPal Inc., a leading Canadian supplier of custom premixes and nutritional supplements.
Stirling Products (ASX: STI) advises that it has successfully signed a Letter of Intent (LOI) and finalised a Term Sheet with a leading and progressive USA nutritional feed premix manufacturer and distributor.
Stirling Products Limited (ASX: STI) advises shareholders that studies recently conducted at the University of Western Australia have confirmed the superior biological potency of R-salbutamol over racemic salbutamol.
